Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-402,563	Closed	-$10.8M	–	467
2025 Q4	$10.8M	Buy	402,563 +76,380	+23%	+$1.97M	0.03%	218
2025 Q3	$8.69M	Sell	326,183 -39,737	-11%	-$1.03M	0.03%	288
2025 Q2	$8.4M	Buy	365,920 +95,770	+35%	+$2.38M	0.03%	304
2025 Q1	$7.83M	Buy	270,150 +32,630	+14%	+$1.04M	0.03%	285
2024 Q4	$8.82M	Buy	237,520 +14,900	+7%	+$681K	0.03%	290
2024 Q3	$10.8M	Buy	+222,620	New	+$9.77M	0.04%	212

Other funds holding AMPH

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return